Home Health Anti-Covid treatments: an arsenal still incomplete

Anti-Covid treatments: an arsenal still incomplete


SAs soon as the Sars-CoV-2 genome was known, researchers from all continents embarked on an arms race against Covid-19. On the “upstream” front, that of vaccination, the success has been breathtaking: development and production speed records have been shattered. In less than a year, the first vaccine was ready. On the “downstream” side, that of treatments, the results are most mixed: two years of pandemic, a lot of trial and error and announcement effects. And often, much ado about nothing.

Paxlovid, the first “anti-Covid pill”

The therapeutic arsenal, however, timidly, is enriched. Since February 4, 2022, Paxlovid, an antiviral drug against Covid developed by Pfizer laboratories, has been available in community pharmacies. A…